New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the May 2016 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the May issue!
PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity
|Lead Type||April 2016||CY 2016|
|Total Drug Leads||347||1377|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Karus Therapeutics Ltd plans to initiate a Phase I study in Q3 of 2016 with KA2507 as a treatment for multiple myeloma:
- Therapeutic Area: Oncology – Other
- Dosage Form: Oral
- API: Chemical – Normal potency
Get deeper information about the likely upcoming needs of Karus Therapeutics, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.
Using the PharmSource Lead Sheet for Trend Analysis
by Brooke Wilson, Senior Research Analyst
We aren’t just interested in weekly leads here at PharmSource, but in trends over months, and from year-to-year. The dashboard you land on each week when you click on your PharmSource Lead Sheet link immediately delivers you a visual depiction of weekly trends broken down in a variety of different ways, including by Development Phase, APIs, Dosage Forms and Therapeutic Areas. You can also see a breakdown of leads geographically and… read on
Lead Generation: Two Cardinal Rules for CRM Success
Customer Relationship Management (CRM) software should measurably improve business outcomes. When well implemented and expertly managed, it can yield significant gains in internal productivity and promote company-wide collaboration.
Data is the linchpin on which CRMs rest, and this foundation needs to be soundly built and maintained. This requires that marketing, inside sales and field sales staff all embrace data entry and upkeep religiously. A systematic approach is required to ensure that new data is both appropriate and accurate, and existing data is updated in a timely way.
Because we specialize in lead-generation, data input is the closest CRM component to our wheelhouse. There are two cardinal rules for CRM success… read on
Follow the Money to
Medical Device & Diagnostic Opportunities
Spotlight on Organogenesis, Inc.
Organogenesis is a private US company that focuses on regenerative medicine, specializing in bio-active wound healing, oral regeneration and bio-surgery. They raised $30 million in a completion of a venture capital investment.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds for new product development and to support the expansion of… read on
Follow the Money to
Spotlight on Aradigm Corporation
Aradigm is a U.S. public biopharmaceutical company that develops and commercializes drugs delivered by inhalation for the treatment of severe respiratory disease. They plan to raise $23 million in a completion of a private debt placement.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support current clinical development and regulatory submission of… read on
Do you know the best target opportunities for your CMO?
We do… and now you can, too.
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at email@example.com / 1-703-383-4903, ext. 112 (ET USA).